NCT04061265View on ClinicalTrials.gov

Articaine Efficacy and Safety for Children Below Age of 4-years

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

August 25, 2019

Primary Completion Date

January 15, 2020

Study Completion Date

January 15, 2020

Conditions
Behaviour AssessmentPain
Interventions
DRUG

Articaine 4%/Epi 1:100000 Inj Cart 1.7Ml

Local anesthetic agent

DRUG

lidocaine hydrochloride 2% and epinephrine 1:100000

Local anesthetic agent

Trial Locations (1)

61111

Ngwa Khattab, Minya

All Listed Sponsors
lead

Minia University

OTHER

NCT04061265 - Articaine Efficacy and Safety for Children Below Age of 4-years | Biotech Hunter | Biotech Hunter